The effect of IFNβ-1b on the evolution of enhancing lesions in secondary progressive MS

Neurology

Volumn 57, Issue 12, 2001, Pages 2185-2190

  Brex, P A ^a   Molyneux, P D ^a   Smiddy, P ^b   Barkhof, F ^c   Filippi, M ^d   Yousry, T A ^e   Hahn, D ^f   Rolland, Y ^g   Salonen, O ^h   Pozzilli, C ⁱ   Polman, C H ^c   Thompson, A J ^a   Kappos, L ^j   Miller, D H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF MILAN   (Italy)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f UNIVERSITY OF WÜRZBURG   (Germany)

^g RENNES UNIVERSITY HOSPITAL   (France)

^h UNIVERSITY OF HELSINKI   (Finland)

ⁱ POLICLINICO UMBERTO I   (Italy)

^j UNIVERSITY HOSPITAL BASEL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON BETA SERINE; BETA INTERFERON; INTERFERON BETA-1B;

ADULT; ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EVOLUTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME; WHITE MATTER; BRAIN; DRUG EFFECT; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ADULT; BRAIN; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE;

EID: 0035956490     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.12.2185     Document Type: Article

References (29)

1. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis
2. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications
3. Hypointense multiple sclerosis lesions on T1-weighted spin echo magnetic resonance images: Their contribution in understanding multiple sclerosis evolution
4. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology
5. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis
6. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability
7. Characterization of multiple sclerosis plaques with T1-weighted MR and quantitative magnetization transfer
8. Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy
9. Lesion heterogeneity in MS: A study of the relationships between appearance on T1-weighted images, T1 relaxation times and metabolite concentrations
10. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
11. Correlating MRI and clinical disease activity in multiple sclerosis: Relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images
12. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis
13. The relationship between T1 lesion load and cerebral atrophy in multiple sclerosis
14. T1 hypointense lesion load in secondary progressive multiple sclerosis: A comparison of pre versus post contrast loads and of manual versus semi automated threshold techniques for lesion segmentation
15. The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsingremitting multiple sclerosis
16. Magnetic resonance imaging changes with recombinant human interferon-beta-1a: A short term study in relapsing-remitting multiple sclerosis
17. Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of relapses and disability by interferon-beta1a subcutaneously in multiple sclerosis
18. Cumulative effect of a weekly low dose of interferon beta 1a on standard and triple dose contrast-enhanced MRI from multiple sclerosis patients
19. Effect of interferon-beta1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: Results of a European multicenter, randomized, double-blind, placebo-controlled trial
20. Magnetic resonance imaging outcome of new enhancing lesions in relapsing-remitting multiple sclerosis patients treated with interferon beta1a
21. MRI evolution of new MS lesions enhancing after different doses of gadolinium
22. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis
23. Interferon-beta-1a in relapsing-remitting multiple sclerosis: Effect on hypointense lesion volume on T1 weighted images
24. T(1) hypointense lesions in secondary progressive multiple sclerosis: Effect of interferon beta-1b treatment
25. A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a
26. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
27. Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial
28. Patterns of lesion development in multiple sclerosis: Longitudinal observations with T1-weighted spin-echo and magnetization transfer MR
29. Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis